Type 2 diabetes mellitus (T2DM) is a leading risk factor for cardiovascular complications
around the globe and one of the most common medical conditions. Atrial fibrillation (AF) is …

Patients with atrial fibrillation (AF) experiencing ischemic stroke despite oral anticoagulation
(OAC), ie, breakthrough strokes, are not uncommon, and represent an important clinical …

BACKGROUND: PINNACLE FLX (Protection Against Embolism for Nonvalvular AF Patients:
Investigational Device Evaluation of the WATCHMAN FLX LAA Closure Technology) …

Background The benefit related to the use of preprocedural computed tomography
angiography (CCTA) on top of periprocedural echocardiography to plan percutaneous left …

Aims Patients with atrial fibrillation who despite taking oral anti-coagulant therapy (OAT)
suffer a stroke or systemic embolism (SSE) without vascular cause or who develop left atrial …

Left atrial appendage occlusion (LAAO) is rapidly growing as valid stroke prevention therapy
in atrial fibrillation. Cardiac imaging plays an instrumental role in preprocedural planning …

Background The interrelationships between left atrial appendage (LAA) dimensions and
device following implantation are unknown. We aimed to analyze the impact of Watchman …

Background Long-term oral anticoagulation is the mainstay therapy for thromboembolic (TE)
prevention in patients with atrial fibrillation. However, left atrial appendage occlusion (LAAO) …

Aims Left atrial appendage occlusion (LAAO) with WATCHMAN device is being used for
patients with atrial fibrillation (AFB) and, as an off-label use, atrial flutter (AFL) who can't …

Intracardiac echocardiography (ICE) has emerged as an alternative to transesophageal
echo (TEE) to guide left atrial appendage occlusion (LAAO). We established a protocol to …